ALK-Abello A/S (AKBLF)
38.89
0.00 (0.00%)
USD |
OTCM |
May 19, 16:00
ALK-Abello EPS Diluted (Quarterly) : 0.3088 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Novo Nordisk A/S | 1.709 |
| H. Lundbeck A/S | 0.2616 |
| AstraZeneca PLC | 0.9849 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 68.43M |
| Revenue (Quarterly) | 277.34M |
| Total Expenses (Quarterly) | 208.91M |
| Enterprise Value | 8.442B |
| Gross Profit Margin (Quarterly) | 69.34% |
| Profit Margin (Quarterly) | 24.68% |
| Earnings Yield | 2.31% |
| Operating Earnings Yield | 3.16% |
| Normalized Earnings Yield | 2.310 |